March 25-27, 2022 – Lake Louise, Alberta
This meeting has been designed to meet the educational needs of hematologists, oncologists, general practitioners in oncology and other health care providers involved in the management of patients with lymphoproliferative and plasma cell disorders.
VIEW THE RECORDED SESSIONS
WELCOME TO CCOLD 2022
Please join us for the 12th Annual Canadian Conference on Lymphoproliferative Disorders (CCOLD) taking place as a hybrid conference in Lake Louise, Alberta on March 25 to 27, 2022.
CCOLD provides a unique opportunity for attendees to interact with international experts in the field of hematologic malignancies. The scope of this meeting will highlight both recent research findings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of our patients. As in previous meetings the format will be didactic presentations as well as case based panel discussions. There will be opportunity for audience participation via keypad polling devices with the entire faculty featured during the panel discussions.
Internationally known researchers in Lymphoproliferative Disorders will provide keynote lectures and their perspectives on optimal management.
We will continue to support the “Young Investigators Research Awards Program” which has been very successful in providing educational and research support to trainees interested in Lymphoproliferative Disorders. Posters outlining their research will be focused at a special reception Saturday afternoon.
The organizing committee for the Allied Health Care Session is in the process of setting up a lively agenda for Friday morning/afternoon.
We look forward to seeing you at this educational event!
Yours truly,
CCOLD Co-Chairs
Dr. Wendy Lam, Burnaby, BC
Dr. Laurie Sehn, Vancouver, BC
On behalf of the CCOLD Planning Committee
Dr. Anca Prica, Toronto, ON
Dr. Pamela Skrabek, Winnipeg, MB
Dr. Carolyn Owen, Calgary, AB
Dr. Darrell White, Halifax, NS
Dr. Nathalie Johnson, Montreal, QC
Dr. Irwindeep Sandhu, Edmonton, AB
Dr. Julie Stakiw, Saskatoon, SK
TARGET AUDIENCE
This meeting has been designed to meet the educational needs of hematologists, oncologists, general practitioners in oncology and other health care providers involved in the management of patients with lymphoproliferative and plasma cell disorders.
LEARNING OBJECTIVES
Highlighting both recent research findings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of our patients.
Young Investigators Research Awards Program
Call for Abstracts
Deadline for Submission February 23, 2022
The CCOLD Young Investigators Research Awards Program aims to provide educational and research support to trainees interested in the area of lymphoproliferative (including plasma cell) disorders. Trainees at any level, confirmed by letter of training from their program director, are eligible to submit an abstract of their work. Abstracts presented at previous meetings, but not in full publication, are allowed for submission. All selected abstracts will be presented during a special Young Investigators Poster Session on the Saturday afternoon/evening at the CCOLD meeting in Lake Louise. Funding will be provided for successful Young Investigators Research candidates. Funding is based on province of applicant.
Please see your program director for application or email nancy@haymatick.com
Please submit applications by February 23, 2022 to: pskrabek@cancercare.mb.ca
ACCREDITATION:
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of
Certification program of the Royal College of Physicians and Surgeons of Canada.
This activity was approved by the Canadian Association of Medical Oncologists for a maximum
of 10.5 hours.
A SPECIAL THANKS TO OUR AFFILIATES
COVID 19 GUIDELINES
While most COVID-19 restrictions have been lifted in Alberta, as health care professionals, we recognise that the COVID-19 pandemic is not over and we continue to be respectful of the risk of COVID-19 for vulnerable people. We ask that all meeting attendees be vaccinated against COVID-19 and to self-screen for COVID-19 symptoms. Do not attend any meetings if you have ILI-like symptoms. Please attempt to maintain physical distancing where possible and consider wearing a mask when not eating/drinking and/or where physical distancing is not possible.